Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HHC will - over the next 2 Weeks and hit - by . In that time frame, HHC's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
HHC shares rose +0.15% in Friday, August 11, 2023's trading session, rising from a previous close of $78.64 to move at $78.76. The stock demonstrated notable intraday movement (see HHC's key stats for a full breakdown), fluctuating between $77.38 and $79.26, a +2.43% trading range. While recent weeks have seen some volatility, HHC has managed to secure a +4.75% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 133.36K shares changing hands, 56.67K fewer than the previous session. This amounted to $10.50M in total market activity.
Will HHC Continue Its Trend?
According to analyst ratings and projections for HHC, The Howard Hughes Corporation shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for HHC. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the HHC stock forecast, now is not the best time to buy HHC stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on HHC covering social and institutional perspectives.
HHC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HHC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 47.31% to 48.57%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.46%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.09%, maintains a neutral outlook for the long term. Insights into HHC's shareholder base show how institutional investors are positioning themselves during these momentum shifts

